Literature DB >> 11566274

Photomedicine: lessons from the Smith-Lemli-Opitz syndrome.

A Anstey1.   

Abstract

The Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder caused by a discrete block in the cholesterol biosynthetic pathway. Recognition of the metabolic basis of this condition has bought into focus knowledge from fields as diverse as clinical genetics, sterol biochemistry, foetal nutrition, and experimental teratology, resulting in a rush of new insights in these fields. Unfortunately, late recognition of photosensitivity as part of this syndrome has largely excluded photodermatologists and photobiologists from the recent frenzy of research in this disorder. However, clinical features of this new inherited photosensitivity syndrome have now been established, and monochromator light testing has confirmed it to be a UVA-mediated condition. Current knowledge concerning photosensitivity in SLOS is reviewed and future research into the pathogenesis of this disorder is discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11566274     DOI: 10.1016/s1011-1344(01)00171-3

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  3 in total

1.  Vitamin D levels in Smith-Lemli-Opitz syndrome.

Authors:  Miyad Movassaghi; Simona Bianconi; Richard Feinn; Christopher A Wassif; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2017-08-10       Impact factor: 2.802

2.  Vitamin D status in patients affected by Smith-Lemli-Opitz syndrome.

Authors:  M Rossi; G Federico; G Corso; G Parenti; A Battagliese; A R Frascogna; R Della Casa; A Dello Russo; P Strisciuglio; G Saggese; G Andria
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Photosensitivity in Smith-Lemli-Opitz syndrome: a flux balance analysis of altered metabolism.

Authors:  Bell Raj Eapen
Journal:  Bioinformation       Date:  2007-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.